Total Payments
$3,535
2024 Payments
$250.00
Companies
19
Transactions
36
Medicare Patients
3,972
Medicare Billing
$557,536
Payment Breakdown by Category
Food & Beverage$3,535 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,535 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $845.99 | 7 | $0 (2024) |
| ABBVIE INC. | $372.43 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $371.26 | 4 | $0 (2022) |
| Biogen, Inc. | $315.77 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $238.88 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $224.27 | 2 | $0 (2022) |
| Allergan Inc. | $139.35 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| SK Life Science, Inc. | $125.00 | 1 | $0 (2022) |
| Amgen Inc. | $124.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.00 | 2 | ABBVIE INC. ($125.00) |
| 2023 | $23.51 | 1 | Axonics, Inc. ($23.51) |
| 2022 | $1,078 | 9 | AstraZeneca Pharmaceuticals LP ($367.89) |
| 2021 | $750.35 | 11 | E.R. Squibb & Sons, L.L.C. ($251.35) |
| 2020 | $124.96 | 1 | Biogen, Inc. ($124.96) |
| 2019 | $841.30 | 7 | AstraZeneca Pharmaceuticals LP ($353.10) |
| 2018 | $466.96 | 5 | Allergan Inc. ($139.35) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Urology | ||||||
| 11/30/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $116.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $99.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.71 | General |
| Category: Respiratory | ||||||
| 03/31/2022 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 03/30/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Respiratory | ||||||
| 03/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.91 | General |
| Category: Cardiovascular | ||||||
| 11/17/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $117.53 | General |
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $122.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.39 | General |
| Category: Cardiovascular | ||||||
| 09/16/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Cardiovascular | ||||||
| 09/08/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $65.85 | General |
| Category: NEUROLOGY | ||||||
| 09/02/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 08/31/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: PDP | ||||||
| 08/10/2021 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $116.83 | General |
| Category: EPILEPSY | ||||||
| 08/09/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINE | ||||||
| 08/03/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/04/2020 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,088 | 1,651 | $595,601 | $141,439 |
| 2022 | 12 | 1,032 | 1,696 | $601,403 | $140,921 |
| 2021 | 14 | 1,034 | 1,605 | $538,211 | $132,851 |
| 2020 | 8 | 818 | 1,462 | $571,768 | $142,325 |
Total Patients
3,972
Total Services
6,414
Medicare Billing
$557,536
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 251 | 413 | $168,989 | $44,326 | 26.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 191 | 349 | $126,923 | $24,835 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 160 | $74,720 | $17,387 | 23.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 161 | 164 | $66,111 | $17,046 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 145 | $47,995 | $10,492 | 21.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 43 | 88 | $32,736 | $8,423 | 25.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 33 | 96 | $25,248 | $6,342 | 25.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 21 | $13,293 | $3,469 | 26.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $16,380 | $3,364 | 20.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 18 | 18 | $8,262 | $2,085 | 25.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 20 | 20 | $6,100 | $1,370 | 22.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,734 | $1,004 | 57.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $1,092 | $503.72 | 46.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 35 | $2,625 | $411.60 | 15.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 60 | 81 | $2,997 | $340.80 | 11.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 12 | $396.00 | $40.92 | 10.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 281 | 576 | $221,760 | $53,920 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 231 | 452 | $142,380 | $29,856 | 21.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 179 | 185 | $73,815 | $17,673 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 140 | $65,380 | $15,095 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 184 | $60,904 | $14,673 | 24.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 27 | $20,358 | $4,966 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $8,554 | $2,182 | 25.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,920 | $1,368 | 71.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $1,560 | $706.52 | 45.3% |
About Halyna Chykyda
Halyna Chykyda is a Internal Medicine healthcare provider based in Port Jefferson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1881073740.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Halyna Chykyda has received a total of $3,535 in payments from pharmaceutical and medical device companies, with $250.00 received in 2024. These payments were reported across 36 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,535).
As a Medicare-enrolled provider, Chykyda has provided services to 3,972 Medicare beneficiaries, totaling 6,414 services with total Medicare billing of $557,536. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Local Education Agency (LEA)
- Location Port Jefferson, NY
- Active Since 05/26/2015
- Last Updated 09/13/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881073740
Products in Payments
- LOKELMA (Drug) $353.10
- ELIQUIS (Drug) $287.60
- BREZTRI (Drug) $246.68
- FARXIGA (Drug) $246.21
- XARELTO (Drug) $238.88
- MULTAQ (Drug) $224.27
- BOTOX (Biological) $139.35
- JARDIANCE (Drug) $125.00
- RINVOQ (Biological) $125.00
- XCOPRI (Drug) $125.00
- Aimovig (Biological) $124.96
- TYSABRI (Biological) $124.96
- NUPLAZID (Drug) $124.77
- SKYRIZI (Biological) $124.58
- UBRELVY (Drug) $122.85
- VALTOCO (Drug) $116.83
- AJOVY (Drug) $115.76
- OCREVUS (Biological) $110.00
- NORTHERA (Drug) $92.61
- ADUHELM (Biological) $65.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Port Jefferson
Dr. Norman Bennett, M.d, M.D
Internal Medicine — Payments: $51,558
Internal Medicine $51,558
Dr. Kenneth Fishberger, Md, MD
Internal Medicine — Payments: $8,334
Internal Medicine $8,334
Sung Whang, Md, MD
Internal Medicine — Payments: $5,126
Internal Medicine $5,126
Phillip Berges
Internal Medicine — Payments: $3,799
Internal Medicine $3,799
Georgia Kulina, M.d, M.D
Internal Medicine — Payments: $3,665
Internal Medicine $3,665
Alexander Gorbatsevich, M.d, M.D
Internal Medicine — Payments: $2,544
Internal Medicine $2,544